Learn More
Medchemexpress LLC Semaglutide-13C6,15N (TFA) | 96.0% | 4120.53 (free acid) | 500 UG

Supplier: Medchemexpress LLC HY114118S3500UG
Semaglutide-13C6,15N TFA is a 13C- and 15N-labeled form of Semaglutide TFA. This compound is a long-acting, selective, competitive GLP-1R agonist capable of penetrating the blood-brain barrier. It promotes insulin secretion, inhibits gastric emptying and appetite, enhances autophagy, inhibits oxidative stress and apoptosis, and regulates mitochondrial function and lipid metabolism.
- Used as a tracer.
- Serves as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
- Known for lowering blood sugar and reducing weight.
- Provides neuroprotection, including improving motor function in Parkinson's disease models.
- Improves hepatic steatosis.
- Applied in research for type 2 diabetes, obesity, Parkinson's disease, MASLD, and cancer.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.